CD19 and cancer: Here, we observed that NALM6 CD19 levels showed high instability throughout co-cultivation, evidenced by the occurrence of a CAR T cell-resistant CD19low relapse-like phenotype of the NALM6 cancer cells during co-cultivation, as also observed by others26,93–95 (Fig. 5d).